ACHV Stock — Achieve Life Sciences Inc

Achieve Life Sciences Inc (ACHV)

Updated October 16, 2026.

ACHV is a Stock. Total return is -100.0% over the past 31 years, 2230.5 points behind SPY at 2130.5%.

Achieve Life Sciences is a late-stage pharmaceutical company developing cytisinicline, a naturally occurring compound designed to reduce nicotine withdrawal symptoms and support smoking cessation in Canada, the United States, and the United Kingdom. The company does not currently distribute dividends to shareholders. This security appeals primarily to growth-oriented investors interested in early-stage pharmaceutical development rather than those seeking current income.

ACHV performance versus SPY

Price and return data through 2026-10-16.

Total return is -100.0% over the past 31 years, 2230.5 points behind SPY at 2130.5%. Over the past year its total return — price change plus distributions reinvested — is 107.1%. Its deepest 1-year drawdown was 54.5%.

ACHV key facts

Asset type

Stock

Asset class

Equity

Inception date

10/12/1995

Distribution frequency

None

Last close

$6.38 (as of 2026-10-16)

Market cap

$657,793,886

Average volume

1992854.0

Payment date

07/31/2020

Beta

2.309

Payout ratio

0.0%

Forward P/E

35.3357

EPS

$-1.69

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

ACHV risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 54.5%.

Who may consider ACHV — and who may not

It is a weaker fit for investors who need monthly cash flow (ACHV does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on ACHV

• All tickers starting with A

Tagged: Healthcare.

Frequently asked questions